FIELD: medicine.
SUBSTANCE: there are developed new prolonged-release pharmaceutical compositions containing ceftiofur crystalline free acid and a carrier containing (i) a modified base oil and (ii) a unmodified base oil.
EFFECT: prolonged release of a bioactive agent.
12 cl, 2 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR MEASUREMENT OF DISSOLVING RATE OF ANALYZED SUBSTANCE IN NONAQUEOUS LIQUID COMPOSITION | 2003 |
|
RU2300766C2 |
DISPERSIBLE PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2311201C2 |
DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
2-S-BENZYLSUBSTITUTED PYRIMIDINES AS CRTH2 ANTAGONISTS | 2008 |
|
RU2491279C2 |
METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
ALKYLTHIOPYRIMIDINES AS CRTH2 ANTAGONISTS | 2008 |
|
RU2491280C2 |
ANTIBIOTIC CONJUGATE AND ANTIBACTERIAL MEDICINAL AGENT BASED ON SAID CONJUGATE | 2007 |
|
RU2371447C2 |
CRYSTALLINE FREE CEFTHIOFURIC ACID, COMPOSITION ON SAID AND METHOD OF ITS SYNTHESIS | 1994 |
|
RU2136685C1 |
PURIFIED DERIVATIVE OF CYCLODEXTRINE, CLATHRATE COMPLEX OF PURIFIED DERIVATIVE OF CYCLODEXTRINE WITH DRUG, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2099354C1 |
BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS FOR PRODUCING AND USING THEM | 2012 |
|
RU2573388C2 |
Authors
Dates
2010-10-10—Published
2003-11-17—Filed